Patents Assigned to Stichting Biomedical Primate Research Centre
  • Patent number: 9879323
    Abstract: The invention relates to the typing of MHC-DRB loci in mammals. In particular, the invention provides a typing procedure for the mammalian DRB region that allows an easy, economical, high resolution, fast and accurate haplotyping protocol. The invention further provides the use of said typing procedure in genetic applications, and provides a kit for typing of MHC-DRB loci.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: January 30, 2018
    Assignee: STICHTING BIOMEDICAL PRIMATE RESEARCH CENTRE
    Inventors: Ronald Edward Bontrop, Gabriele Gerda Maria Doxiadis
  • Patent number: 9127315
    Abstract: The invention relates to the typing of MHC-DRB loci in mammals. In particular, the invention provides a typing procedure for the mammalian DRB region that allows an easy, economical, high resolution, fast and accurate haplotyping protocol. The invention further provides the use of said typing procedure in genetic applications, and provides a kit for typing of MHC-DRB loci.
    Type: Grant
    Filed: April 10, 2008
    Date of Patent: September 8, 2015
    Assignee: STICHTING BIOMEDICAL PRIMATE RESEARCH CENTRE
    Inventors: Ronald Edward Bontrop, Gabriele Gerda Maria Doxiadis
  • Patent number: 8741305
    Abstract: The present invention relates to a protein composition suitable for inducing an immune response in a vertebrate comprising 2 to 10 protein variants of a single antigen, which is the APICAL MEMBRANE ANTIGEN 1 (PfAMA1 OR AMA1) of a Plasmodium species. The antigen comprises a plurality of variable amino acid positions, wherein the amino acid sequences of said protein variants, in combination, represent both the frequency of occurrence of each amino acid at said variable amino acid positions and the linkage between the variable amino acid positions, and wherein said frequency of occurrence is at least between 10% to 20% such as 10%, 11%, 12%, 13%, . . . , 20% in the single antigen, and wherein at least 75% of the linkages between the variable amino acid position is presented by the combination of protein variants.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: June 3, 2014
    Assignee: Stichting Biomedical Primate Research Centre
    Inventors: Alan William Thomas, Clemens Hendricus Martinus Kocken, Bart Willem Faber, Edmond Joseph Remarque
  • Patent number: 7910330
    Abstract: A method of efficiently expressing Plasmodium AMA-1 ectodomain or a functional part, derivative, and/or analogue thereof, in a eukaryotic expression system. Preferably, the Plasmodium AMA-1 ectodomain is Pf AMA-1 ectodomain. This protein may be expressed in yeast, such as Pichia pastoris. Efficient expression is possible using a method for producing mRNA encoding the Plasmodium AMA-1 ectodomain in a yeast cell, comprising providing the yeast cell with a nucleic acid encoding Plasmodium AMA-1 ectodomain, the nucleic acid being modified to utilize the yeast cell's codon usage. Preferably, at least one putative yeast polyadenylation consensus sequence in the nucleic acid has been modified. More preferably, also at least one site in the protein that is generally glycosylated by eukaryotic expression systems, has been removed.
    Type: Grant
    Filed: July 8, 2003
    Date of Patent: March 22, 2011
    Assignee: Stichting Biomedical Primate Research Centre
    Inventors: Clemens Hendricus M. Kocken, Alan William Thomas, Michael John Blackman, Chrislaine Withers-Martinez, Anthony Arthur Holder
  • Publication number: 20100172923
    Abstract: The present invention relates to a protein composition suitable for inducing an immune response in a vertebrate comprising 2 to 10 protein variants of a single antigen, which is the APICAL MEMBRANE ANTIGEN 1 (PfAMA1 OR AMA1) of a Plasmodium species. The antigen comprises a plurality of variable amino acid positions, wherein the amino acid sequences of said protein variants, in combination, represent both the frequency of occurrence of each amino acid at said variable amino acid positions and the linkage between the variable amino acid positions, and wherein said frequency of occurrence is at least between 10% to 20% such as 10%, 11%, 12%, 13%, . . . , 20% in the single antigen, and wherein at least 75% of the linkages between the variable amino acid position is presented by the combination of protein variants.
    Type: Application
    Filed: December 21, 2006
    Publication date: July 8, 2010
    Applicant: STICHTING BIOMEDICAL PRIMATE RESEARCH CENTRE
    Inventors: Alan William Thomas, Clemens Hendricus Martinus Kocken, Bart Willem Faber, Edmond Joseph Remarque
  • Patent number: 6783762
    Abstract: A large number of recombinant of viral and bacterial systems has been engineered as vectors to express foreign genes for vaccination and/or gene therapy. A common problem is the immune response to the vector itself. The presence of anti-vector immune response may preclude sufficient priming or delivery if pre-existing immune responses are present, or impair optimal “boosting” upon subsequent immunisation or delivery. The invention provides means and methods for vaccinating an animal or a human to obtain therein an immune response against at least one antigen, comprising different vaccine compositions for sequential administration to said animal or said human, each containing at least said antigen or a precursor thereof, wherein said vaccine compositions differ from each other by the presence therein of a different vector.
    Type: Grant
    Filed: January 9, 2002
    Date of Patent: August 31, 2004
    Assignee: Stichting Biomedical Primate Research Centre
    Inventor: Jonathan Luke Heeney